Cortene's CT38 drug trial produces "encouraging results" in chronic fatigue syndrome as it finds that lower concentrations of the drug provide better effects - thus validating their hypothesis.
Cort talks about hot topics in fibromyalgia research, future treatment possibilities, diagnosis, the difference between chronic fatigue syndrome and FM and more to the Sheffield ME and Fibromyalgia Association in the UK.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.